ESPID: Researchers Find No Evidence of Need for Hepatitis A Boosters

Vaccination News Home Page                                            subscribe Vaccination NewsLetter

 

http://www.pslgroup.com/dg/2302ea.htm

 

ESPID: Researchers Find No Evidence of Need for Hepatitis A Boosters

By Ed Susman
 

GIARDINI NAXOS, SICILY, ITALY -- April 11, 2003 -- Doctors reported Friday that no data exists indicating that booster vaccinations of hepatitis A vaccine are necessary.
 

"Effective vaccines against hepatitis A have been available since 1992, and they provide long-term immunity against the infection," said Pierre Van Damme, MD, University of Antwerp, Belgium. "There is no worldwide consensus on low long protection will last or whether there will be a need for hepatitis A booster vaccinations in the future."
 

In a post presentation at the 21st Annual Meeting of the European Society for Paediatric Infections Disease, Dr. Van Damme and colleagues reviewed data from various studies. A panel of experts was convened in June 2002 to review the available data.
 

"The group concluded that there is no evidence to support hepatitis A booster vaccination following successful primary vaccination in a healthy individual, although further investigations are required before deciding if boosters may be omitted in special patient groups," Dr. Van Damme reported.
 

He cited several studies which support the groups conclusion, including indirect evidence of hepatitis A immune memory in a study of 31 adults who, 12 years after inoculation with hepatitis A vaccine, were challenged with an half dose of an adult hepatitis A vaccine and had a corresponding rapid increase in antibody levels.
 

He also cited studies of adult travelers, which showed that a delay in timing of a second dose -- as much as 6 years after the first dose -- does not appear to affect the immune response. Several animal and humans studies also demonstrated long-term cell-mediated responses.
 

Dr. Van Damme said the consensus statement from the panel is expected this year in the medical journal The Lancet.
 

While there is no evidence that immunocompetent individuals who have received a full vaccination course require a booster dose, Dr. Van Damme, said, "long-term studies are recommended in special patients groups -- including immunocompromised patients -- to evaluate antibody persistence and vaccine efficacy."
 

 

[Study title: Are Hepatitis A Booster Vaccinations Necessary? Findings Of The International Consensus Group On Hav Immunity. Abstract 92]

 

Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.
 

Vaccination News Home Page

 

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.